Found: 4
Select item for more details and to access through your institution.
Monoclonal antibody drugs for the treatment of multiple sclerosis and neuromyelitis optica spectrum disorder.
- Published in:
- Clinical & Experimental Neuroimmunology, 2022, v. 13, n. 3, p. 133, doi. 10.1111/cen3.12725
- By:
- Publication type:
- Article
High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD).
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04074-1
- By:
- Publication type:
- Article
Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-70203-x
- By:
- Publication type:
- Article